BMB is a universal platform which can be used for a variety of protein and nucleic acid applications. The molecular diagnostics market consists of fairly mature products for infectious diseases and blood transfusion products as well as newer products for gene-based disorders, blood and organ transplantation, inherited diseases, and cancer. The majority of testing within the molecular diagnostics market consists of nucleic acid-based tests for detecting pathogenic bacteria and viruses. In some cases, these tests can also detect antibiotic resistance. Molecular tests have also made the blood transfusion industry much safer due to their ability to detect lower concentrations of pathogens and viruses in donated blood.